Associated Papers
Deep whole genome sequencing identifies recurrent genomic alterations in commonly used breast cancer cell lines and patient-derived xenograft models.
Deng N et al.
Breast Cancer Research : Bcr, 2022
36153537 (PubMed )
Supplement: 13058_2022_1540_MOESM2_ESM.xlsx › SuppTableS2
Identification of Familial Hodgkin Lymphoma Predisposing Genes Using Whole Genome Sequencing.
Srivastava A et al.
Frontiers in Bioengineering and Biotechnology, 2020
Select a paper to view details